<i>TET2</i>-mutant clonal hematopoiesis and risk of gout
Mridul Agrawal(Dana-Farber Cancer Institute), Benjamin L. Ebert(Dana-Farber Cancer Institute), Alexander G. Bick(Vanderbilt University Medical Center), Waihay J. Wong(Brigham and Women's Hospital), Abhishek Niroula(Broad Institute), Veronica Shkolnik(Dana-Farber Cancer Institute), Pradeep Natarajan(Unknown), Peter G. Kim(Boston Children's Hospital), Christopher J. Gibson(Otsuka (Japan)), Amy E. Lin(Brigham and Women's Hospital), Lachelle D. Weeks(Harvard University), Peter A. Nigrović(Brigham and Women's Hospital), Richard M. Stone(Dana-Farber Cancer Institute), Pierre Cunin(Brigham and Women's Hospital), Siddhartha Jaiswal(Stanford University), Aswin Sekar(Dana-Farber Cancer Institute), Deepak A. Rao(Brigham and Women's Hospital), Inga‐Marie Schaefer(Brigham and Women's Hospital), Peter G. Miller(Broad Institute), Gabriel K. Griffin(Brigham and Women's Hospital), Donna Neuberg(Otsuka (Japan)), Marie McConkey(Dana-Farber Cancer Institute), Md Mesbah Uddin(Broad Institute)
Cited by 150
Related Papers
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
|Proceedings of the National Academy of Sciences|2005|56.5k
Analysis of protein-coding genetic variation in 60,706 humans
|Nature|2016|10.3k
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
The landscape of somatic copy-number alteration across human cancers
|Nature|2010|4.1k